Home/Filings/4/0000912282-24-000187
4//SEC Filing

ROBERTS BRIAN KENNETH 4

Accession 0000912282-24-000187

CIK 0001509261other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 8:47 AM ET

Size

6.4 KB

Accession

0000912282-24-000187

Insider Transaction Report

Form 4
Period: 2024-02-23
ROBERTS BRIAN KENNETH
Chief Medical Officer
Transactions
  • Purchase

    Common Shares

    2024-02-23$1.69/sh+6,000$10,14040,552 total
  • Purchase

    Common Shares

    2024-02-26$1.70/sh+2,000$3,40042,552 total
Footnotes (1)
  • [F1]The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.6985, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Rezolute, Inc.

CIK 0001509261

Entity typeother

Related Parties

1
  • filerCIK 0001829608

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:47 AM ET
Size
6.4 KB